NVCT smart money
Nuvectis Pharma, INC. (NVCT): 5 insider buys, 4 top funds holding it in the public filings.
Insider buys, 12 months$2.3M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-07-01 | Mosseri Marlio Charles | TenPercentOwner | $916k | $18.32 |
| 2026-07-01 | Bentsur Ron | Chairman & CEO | $250k | $20.0 |
| 2025-11-06 | Sanchez Juan | Director | $75k | $5.79 |
| 2025-11-06 | Kaplan Matthew L. | Director | $64k | $5.84 |
| 2025-10-29 | Mosseri Marlio Charles | TenPercentOwner | $957k | $6.28 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 13 | Avidity Partners Management LP | TRIM -50% | 0.50% | $2M |
| 22 | Braidwell LP | BUY | 1.43% | $33M |
| 72 | Sphera Funds Management LTD. | TRIM -16% | 1.03% | $7M |
| 84 | Soleus Capital Management, L.P. | ADD +71% | 1.28% | $36M |